Skip to main content

Weight Loss · GLP-1 Program

Tirzepatide online — the strongest trial results in its class.

In clinical trials, the active medication tirzepatide reduced body weight by up to 22%. REMEVi connects you with a licensed provider and ships compounded tirzepatide directly to your door. $249 for your first month ($130 welcome discount applied automatically at checkout), then $379/month — or as low as $269/mo on a 52-week plan ($339/mo 12-week). All-inclusive.

  • 503B pharmacy
  • Licensed providers
  • Free shipping
  • Bilingual support
  • Cancel anytime

Compounded tirzepatide is not FDA-approved and is not a generic version of Mounjaro® or Zepbound®. Your provider prescribes a compounded preparation only when they determine it offers a meaningful clinical difference for you — such as personalized dose titration. Trial results are for the active medication, not REMEVi outcomes.

The science

How tirzepatide works

Tirzepatide is a dual GIP/GLP-1 receptor agonist that mimics two natural hormones to regulate appetite, metabolism, and blood sugar.

Reduces appetite

Signals the brain to eat less and feel full longer.

Slows gastric emptying

Slows food movement through the digestive system.

Improves blood sugar

Regulates glucose and reduces cravings via GIP + GLP-1.

Dual-action mechanism

Activates two receptors for greater weight loss than GLP-1 alone.

Treatment plan

Tirzepatide dosing protocol

Provider-supervised dose escalation every 4 weeks to maximize results and minimize side effects.

Dose escalation

Weeks 1–4

2.5 mg

Starter dose weekly

Weeks 5–8

5 mg

First therapeutic dose

Weeks 9–12

7.5 mg

Increased every 4 weeks

Weeks 13–24

10–15 mg

Titrate to maintenance

Delivery & support

Injection method

Subcutaneous (under the skin)

Frequency

Once per week

Provider check-ins

Monthly dose adjustments

Timeline

Full 24-week program

What to expect

Tirzepatide results timeline

Weight loss milestones and what patients typically experience at each phase.

Weeks 1–4

Appetite suppression

Noticeable decrease in hunger and food cravings begins.

Weeks 5–12

5–10% loss

Body weight reduction of 5–10% is common at this phase.

Weeks 13–24

Up to 15–22%

Total body weight loss in clinical trials (SURMOUNT-1).

Ongoing

Maintenance

Maintenance dosing available to preserve results long-term.

Results vary based on adherence, diet, exercise, and individual metabolism. Your REMEVi licensed provider will monitor your progress and adjust dosing as needed.

All-inclusive

Everything in one price — no surprises.

Unlike Hims, Ro, and Medvi — there are no hidden lab fees or add-on charges.

Licensed US provider

Prescription from a board-certified US licensed provider who reviews your full health history.

503B compounded tirzepatide

Compounded tirzepatide from a 503B-accredited pharmacy under strict quality control.

Free discreet shipping

Medication shipped directly to your door in unmarked packaging. Free every month.

Bilingual support

Care team available in English and Spanish with a 2-hour response target.

Monthly check-ins

Regular check-ins with your care team to adjust dosage and monitor your progress.

LegitScript certified

REMEVi is a LegitScript-certified telehealth platform you can trust.

Real cost comparison

Brand prices climb with your dose. Ours stays flat — at every dose.

Brand-name Zepbound runs $299–$449/mo and rises as you titrate up. REMEVi compounded tirzepatide is $249 your first month ($130 welcome discount applied automatically), then one flat $379 at every dose — with no membership fee.

REMEVi
$249 first month → stays $379
$379/mo
flat at every dose · no fees
MEDVi
$279 to start ↗ up to $399
$399/mo
+$20 vs REMEVi
Zepbound (LillyDirect) brand name
$299–$449, climbs by dose
$449/mo
+$70 vs REMEVi

And it's simpler — one price, everything included

One flat price at every dose
No membership fee
Visit, meds & shipping included
Bilingual care, all 50 states
Far below brand name
See if you qualify Free · no card required

Representative advertised prices as of June 2026, standard dosing. Your price won’t climb with your dose. REMEVi compounded medications are not FDA-approved.
Sources: MEDVi, Zepbound (LillyDirect)

The Protocols · Los Protocolos

One price. No surprises.

One flat price at every dose. Most weight-loss programs raise your price every time your dose goes up — REMEVi never does. Visit, medication, coaching and shipping — one number. No separate membership fee. (Many programs add a $79–$149/mo membership on top of the medication price.)

★ FOUNDERS CHOICE · BEST VALUE
REMEVi welcome kit on cream marble: compounded semaglutide injection vial with deep teal cap and prescription label, deep teal velvet pouch, welcome card, and fresh eucalyptus
NPI VERIFIED
INJECTION · GLP-1

Semaglutide Injections

Provider-managed weekly injection. The same compounded GLP-1 as the big-brand competitors — with bilingual care, no insurance, no dose upcharges.

$149 first month $130 OFF
then $279/mo · or as low as $199/mo
Visits, meds, coaching & overnight shipping — all included
  • Bilingual care, every visit (EN · ES)
  • −5″ off the waist in trials¹
Free · no card required Safety information →
NEEDLE-FREE · FOR PILL PREFERRERS
REMEVi compounded oral semaglutide in a deep teal translucent prescription bottle with cream cap, on cream marble with scattered white tablets and fresh eucalyptus
NPI VERIFIED
ORAL TABLET · DAILY

Semaglutide Oral

Daily oral semaglutide. Same clinical oversight, same bilingual care — without the needle.

$219 first month $130 OFF
then $349/mo · or as low as $249/mo
Visits, meds, coaching & overnight shipping — all included
  • Daily tablet — no syringe, no fridge
  • Cancel anytime — no contracts
  • −5″ off the waist in trials¹
Free · no card required Safety information →
★ CLINICIANS' CHOICE · DUAL-AGONIST
REMEVi compounded tirzepatide injection vial with deep teal cap and prescription label, elevated on cream marble pedestal with eucalyptus and teal silk fabric
NPI VERIFIED
INJECTION · GLP-1 + GIP

Tirzepatide Injections

Dual-agonist tirzepatide. The strongest average loss in the GLP-1 category — provider-managed, bilingual care.

$249 first month $130 OFF
then $379/mo · or as low as $269/mo
Visits, meds, coaching & overnight shipping — all included
  • Dual-agonist (GLP-1 + GIP) — faster avg loss
  • NPI-verified compounding pharmacy
  • −22.5% body weight in trials¹
Free · no card required Safety information →

¹ Clinical-trial results for semaglutide (STEP-1, NEJM 2021) and tirzepatide (SURMOUNT-1, NEJM 2022) — the active medications in REMEVi protocols, not REMEVi outcomes or guarantees. Compounded preparations are not FDA-approved and have not been studied as finished products. Individual results vary.

The REMEVi Flat-Dose Guarantee

Your price never rises with your dose. Ever.

Most programs charge more as your dose increases. At REMEVi, your price stays flat at every dose — with no separate membership fee on top of the medication price.

THE 4 QUESTIONS EVERYONE ASKS

Named out loud, answered in full.

REMEVi's semaglutide is compounded by a 503B outsourcing facility registered with the FDA — the same regulatory tier hospitals use. Compounded medications are not FDA-approved finished drug products; they are prepared under the 503A or 503B framework to USP <797> sterility standards and prescribed by a licensed provider in your state who will review the risks, benefits, and considerations with you.

Facility tier
FDA-registered 503B
Sterility standard
USP <797>
Active ingredient
Semaglutide
Provider network
All 50 states + DC

FAQ

Tirzepatide questions answered

Tirzepatide is a dual GIP/GLP-1 receptor agonist medication approved for weight management. It works by reducing appetite and improving blood sugar regulation.

REMEVi prescribes compounded tirzepatide, which is not the same as, and is not a generic version of, Mounjaro® or Zepbound® (FDA-approved finished drug products manufactured by Eli Lilly). Compounded tirzepatide is a non-FDA-approved preparation prepared by a state-licensed compounding pharmacy under an individual prescription from a licensed US provider. Compounded preparations have not been clinically studied as finished products. Your licensed provider will review risks, benefits, and considerations with you before prescribing.

Your first month is $249 ($130 welcome discount applied automatically at checkout). After that it's $379/month on the monthly plan, $339/mo on the 12-week plan, or as low as $269/mo on the 52-week plan. All plans are all-inclusive — no hidden fees.

Clinical trials (SURMOUNT-1) showed tirzepatide at the highest dose produced up to 22% body weight loss, generally outperforming semaglutide trials. Individual results vary.

Most patients notice appetite changes in the first 2–4 weeks. Meaningful weight loss typically becomes visible by weeks 8–12.

Yes. Your REMEVi licensed provider can evaluate a transition during your consultation.

Ready to start?

The secure medical intake takes about 5 minutes. Clinical review within 24 hours. Medication shipped free.

See if you qualify — $249 first month
The GLP-1 Guide · Free

Not ready to start today? Take the guide with you.

What GLP-1 is, how it works, what to expect, and nutrition tips — in English and Spanish. Free, straight to your inbox.

No spam. Unsubscribe anytime.

From $149 first month · −$130 auto-applied See if you qualify →

Free · no card required